Downstream Processing Featured Articles
-
WHO Member States Make Progress On Noncommunicable Diseases
11/12/2012
The first-ever global monitoring framework to combat several of the world’s biggest killers has been agreed this week by WHO Member States. The framework comprises nine voluntary global targets and 25 indicators to prevent and control diseases such as heart disease, diabetes, cancer, chronic lung disease and other noncommunicable diseases.
-
BARDA Continues Novavax' Influenza Vaccine Programs Following In-Process Review
1/24/2013
Novavax, Inc. (Nasdaq:NVAX) today announced that the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority (BARDA) has completed an In-Process Review (IPR) of Novavax' contract covering the company's recombinant virus-like particle (VLP) vaccine candidates for pandemic and seasonal influenza.
-
Saint-Gobain Single-Use Solutions Optimize Bioprocessing Operations
8/1/2013
The economic and operational benefits of single-use technologies have led to increasingly widespread adoption in the biopharmaceutical sector.
-
Successful Immunization And Safety Documented In Nasal Administration Study Of The HIV Vaccine Vacc-4x Together With Endocine
5/10/2012
Bionor Pharma ASA (
OSLO :BIONOR), Eurocine Vaccines AB and Oslo University Hospital today announced that vaccine related immune responses are documented in patients given active vaccine in a nasal immunization study, combining Bionor Pharma's Vacc-4x and Eurocine Vaccines' adjuvant Endocine. -
Dr. Brad Vince Of Vince & Associates Clinical Research Announces Award Of Nearly $10M Contract From The National Institute On Drug Abuse
9/19/2012
Vince & Associates Clinical Research announced it has been awarded a contract with the National Institute on Drug Abuse, part of the National Institutes of Health (NIH), to carry out clinical pharmacology studies to determine the pharmacokinetics and pharmacodynamics of new medication in humans.
-
Researchers' Sequencing Of Human and Monkey Malaria Genomes Reveals Challenges, Opportunities In Battle Against Parasite
8/5/2012
Genetic variability revealed in malaria genomes newly sequenced by two multi-national research teams points to new challenges in efforts to eradicate the parasite, but also offers a clearer and more detailed picture of its genetic composition, providing an initial roadmap in the development of pharmaceuticals and vaccines to combat malaria.
-
GeoVax Awarded $1.9 Million Grant By US Government For HIV/AIDS Vaccine Program
10/1/2012
GeoVax Labs, Inc. (
OTCQB : GOVX), an Atlanta-based biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, announced receipt of a $1.9 million award from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, supporting the development of a clade C version of the Company's current clade B vaccine products. -
Saint-Gobain Performance Plastics Acquires Twin Bay Medical
12/3/2012
Saint-Gobain Performance Plastics has completed the acquisition of Twin Bay Medical, a Michigan based innovator and manufacturer of BarbLock® products - flexible tube retainers - as well as single-use components for biopharmaceuticals manufacturing.
-
Novartis To Start Construction Of New Biotechnology Facility In Singapore With An Investment Of Over USD 500 Million
10/31/2012
Novartis announced recently the construction of a new state-of-the-art biotechnology production site in Singapore with an investment valued at over USD 500 million. The new facility will focus on drug substance manufacturing based on cell culture technology.
-
Mayo Clinic Uses New Approach To Reverse Multiple Sclerosis In Mice Models
6/28/2012
Mayo Clinic researchers have successfully used smaller, folded DNA molecules to stimulate regeneration and repair of nerve coatings in mice that mimic multiple sclerosis (MS). They say the finding, published today in the journal PLoS ONE, suggests new possible therapies for MS patients.